Munich Personal RePEc Archive
metadata only
Market Effects of Generic Entry: The Role of Physicians and of Non-Bioequivalent Competitors
Patent expiration represents a turning point for the brand losing patent protection as bioequivalent generic versions of the drug quickly enter the market at reduced prices. In this paper, we study how physician characteristics and their prescribing decisions impact the competition among molecules o
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Patent Strategies and Competition Law in the Pharmaceutical Sector: Implications for Access to Medicines#271000
- In re Generic Drug Pricing Antitrust Litigation#609588
- Amendment of Pharmaceutical Affairs Law#69322
- Price, Property and Trade Across a Regulatory Border: Pharmaceuticals (Re)importation from Canada and Beyond#641626
- Mitsubishi Motors Corp. v. Colemon: Broad Reading of Innovative Clinical Leads to General Personal Jurisdiction Under Georgia's Long-Arm Statute#183613
Record · ID 1275629
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive